{"gene":"GPR39","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1997,"finding":"GPR39 was cloned as a member of the GHS-R/neurotensin receptor family, sharing structural features including a conserved acidic residue (E124) in TM-3 essential for GHS-R activation; expressed in brain and peripheral tissues.","method":"cDNA cloning, genomic hybridization, sequence analysis","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — original cloning paper with structural characterization, single lab","pmids":["9441746"],"is_preprint":false},{"year":2006,"finding":"Zn2+ activates GPR39 signaling (inositol phosphate turnover, cAMP production, arrestin mobilization, CRE- and SRE-dependent transcriptional activity) in GPR39-expressing cells; obestatin does not activate GPR39 or bind to it.","method":"Cell-based signaling assays (IP turnover, cAMP, arrestin recruitment, reporter gene), radioligand binding, quantitative PCR","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal signaling assays, replicated across labs","pmids":["16959833","17054911"],"is_preprint":false},{"year":2007,"finding":"Zn2+ was isolated as an endogenous GPR39 agonist from fetal bovine serum; its calcium-mobilizing activity is abolished by PLC inhibitor U73122 but not pertussis toxin, demonstrating Gαq-PLC coupling; conserved across mouse and rat GPR39.","method":"HPLC fractionation of FBS, ICP-MS identification, intracellular calcium mobilization assay, pharmacological inhibitors","journal":"Journal of receptor and signal transduction research","confidence":"High","confidence_rationale":"Tier 1 — biochemical purification of endogenous agonist plus mechanistic pathway dissection","pmids":["17885920"],"is_preprint":false},{"year":2007,"finding":"GPR39 exists as a full-length 7TM form (GPR39-1a) with constitutive activity and a truncated 5TM splice variant (GPR39-1b); promoter analysis identified HNF-1α, HNF-4α, and SP1 binding sites controlling GPR39 expression.","method":"RT-PCR, quantitative RT-PCR, functional promoter analysis","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — splice variant characterization with functional promoter dissection, single lab","pmids":["17488974"],"is_preprint":false},{"year":2008,"finding":"Zn2+ agonism of GPR39 requires His17 and His19 in the N-terminal extracellular segment; Asp313 in ECL3 functions as a tethered inverse agonist, and its substitution eliminates Zn2+-induced activation while greatly increasing constitutive signaling.","method":"Alanine-scanning mutagenesis, inositol phosphate production assay","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — systematic active-site mutagenesis defining agonist binding mechanism","pmids":["18588883"],"is_preprint":false},{"year":2008,"finding":"GPR39 contains two disulfide bridges: a conserved bridge (Cys108–Cys210) required for cell surface expression and agonist-induced signaling, and a non-conserved bridge (Cys11–Cys191) that dampens receptor activation; disruption of the second bridge increases Zn2+ potency ~10-fold.","method":"Cysteine mutagenesis, TCEP reduction, free sulfhydryl labeling, inositol phosphate assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis plus chemical reduction with complementary readouts","pmids":["18693759"],"is_preprint":false},{"year":2008,"finding":"GPR39 constitutive activity signals via Gα13 → RhoA → SRE-mediated transcription, leading to upregulation of PEDF secretion and protection from cell death; RGS16 was identified as a signaling component linking GPR39 to Gα13.","method":"Transcriptome array, co-expression with dominant-negative RhoA/SRF, GPR39 overexpression/silencing, PEDF conditioned medium assay","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple signaling pathway tests, single lab","pmids":["18180304"],"is_preprint":false},{"year":2010,"finding":"GPR39 is the molecular identity of the zinc-sensing receptor (ZnR) in keratinocytes; silencing GPR39 abolishes Zn2+-dependent metabotropic Ca2+ responses, downstream MAP kinase activation, NHE1 upregulation, and scratch closure.","method":"siRNA silencing of GPR39, fluorometric Ca2+ imaging, MAP kinase assay, scratch wound assay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — siRNA knockdown with multiple orthogonal functional readouts","pmids":["20522546"],"is_preprint":false},{"year":2011,"finding":"Synaptic Zn2+ activates GPR39 (mZnR) postsynaptically to upregulate KCC2 surface expression and Cl- transport activity, producing a hyperpolarizing shift in GABAA reversal potential and enhancing inhibitory tone in hippocampal neurons.","method":"GPR39 knockout mice, mossy fiber stimulation in hippocampal slices, ZnT3-KO mice, EGABA measurement, KCC2 surface expression assay","journal":"Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout, electrophysiology, and biochemistry across multiple mouse models","pmids":["21900570"],"is_preprint":false},{"year":2012,"finding":"GPR39 is identified as the molecular moiety of ZnR in colonocytes; GPR39 silencing abolishes Zn2+-dependent Ca2+ release, Na+/H+ exchange upregulation, and butyrate-induced cell death protection; the protection is mediated by GPR39-dependent clusterin upregulation.","method":"GPR39 siRNA silencing, Ca2+ imaging, NHE activity assay, GPR39 KO mouse tissue, clusterin knockdown","journal":"PLoS ONE","confidence":"High","confidence_rationale":"Tier 2 — siRNA plus KO mouse validation with multiple mechanistic readouts","pmids":["22545109"],"is_preprint":false},{"year":2012,"finding":"Extracellular pH regulates ZnR/GPR39 activity through Asp313: substitution of Asp313 to Ala abolishes pH sensitivity, while His17 and His19 replacements do not affect pH dependence, identifying Asp313 as both a Zn2+-binding modulator and pH sensor.","method":"Site-directed mutagenesis (Asp313, His17, His19), Ca2+ imaging, ERK1/2 and AKT activation assays, NHE activity assay at varying pH","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — structure-function mutagenesis with multiple functional readouts","pmids":["22879599"],"is_preprint":false},{"year":2014,"finding":"GPR39 activates Gαq/11-RhoA signaling to sustain YAP activity in oral squamous cell carcinoma; inhibition of GPR39 reduces YAP-driven tumor growth.","method":"GPR39 overexpression/knockdown, signaling pathway analysis, tumor growth assays","journal":"Journal of Dental Research","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway assignment with functional cancer phenotype, single lab","pmids":["32325008"],"is_preprint":false},{"year":2014,"finding":"GPR39 is identified as the receptor mediating Hedgehog pathway inhibition by CMAP compounds downstream of Smoothened; RNA interference knockdown or cDNA overexpression of GPR39 confirmed necessity for compound activity and Gli transcription factor modulation.","method":"siRNA knockdown, cDNA overexpression, GPCR mRNA expression correlation, Hh pathway reporter assay, IP turnover assay","journal":"Nature Chemical Biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain- and loss-of-function with pathway-level mechanistic readout","pmids":["24633354"],"is_preprint":false},{"year":2014,"finding":"ZnR/GPR39 interacts with the Ca2+-sensing receptor (CaSR) to synergistically enhance Zn2+-dependent Ca2+ signaling; CaSR silencing or dominant-negative CaSR reduces ZnR/GPR39 activity; co-expression is sufficient to trigger enhanced responses.","method":"siRNA silencing of CaSR, dominant-negative CaSR, GPR39 overexpression in HEK293, Ca2+ imaging, MAPK/PI3K assays","journal":"Journal of Cellular Physiology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple complementary approaches in single lab","pmids":["24264723"],"is_preprint":false},{"year":2014,"finding":"ZnR/GPR39 controls colonocyte proliferation and differentiation via ERK1/2, AKT, and mTOR/p70S6K pathways; silencing ZnR/GPR39 impairs alkaline phosphatase activity (differentiation marker) and reduces tight junction protein (occludin, ZO-1, E-cadherin) expression; GPR39 KO mouse colon shows decreased ZO-1 and occludin.","method":"siRNA silencing, Western blot (ERK1/2, AKT, mTOR, caspase-3), alkaline phosphatase assay, TEER measurement, GPR39 KO mice","journal":"Cell Death & Disease","confidence":"High","confidence_rationale":"Tier 2 — siRNA plus KO mouse validation with multiple mechanistic readouts","pmids":["24967969"],"is_preprint":false},{"year":2014,"finding":"Protein kinase inhibitor β (PKIB) interacts with the C-terminus of GPR39 (identified by Y2H screen); co-expression enhances GPR39 constitutive (Gα13/RhoA/SRE) but not zinc-mediated signaling; zinc causes PKIB dissociation from GPR39, creating a negative-feedback loop on Gs pathway.","method":"Yeast-2-hybrid screen, co-expression, SRE reporter assay, cell protection assay, PKIB mutational analysis","journal":"Biochemical Journal","confidence":"Medium","confidence_rationale":"Tier 2 — Y2H binding plus functional validation, single lab","pmids":["24869658"],"is_preprint":false},{"year":2015,"finding":"GPR39 forms heteroreceptor complexes with 5-HT1A and GalR1; these interactions are modulated by zinc; the 5-HT1A-GPR39 heterocomplex shows additive signaling functionality compared to individual receptors.","method":"FRET, co-immunopurification, signaling assays upon receptor activation","journal":"Biochimica et Biophysica Acta","confidence":"Medium","confidence_rationale":"Tier 2 — FRET and co-IP with functional readout, single lab","pmids":["26365466"],"is_preprint":false},{"year":2015,"finding":"mZnR/GPR39 activation by synaptic Zn2+ release upregulates KCC2 via Gαq/phospholipase C/ERK1/2 signaling cascade; mZnR/GPR39 KO mice have dramatically enhanced seizure susceptibility to kainic acid.","method":"GPR39 KO mice, kainic acid seizure model, hippocampal slice electrophysiology, KCC2 surface expression assay, PLC/ERK inhibitors","journal":"Neurobiology of Disease","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with electrophysiology, biochemical pathway dissection","pmids":["25562657"],"is_preprint":false},{"year":2015,"finding":"In human myoblasts, obestatin/GPR39 system controls myogenesis: mitogenic ERK1/2/JunD signaling is G protein-dependent, while cell cycle exit and differentiation require β-arrestin 1/2 scaffolding, Src activation, and EGFR transactivation via matrix metalloproteinases.","method":"β-arrestin knockdown, EGFR transactivation assays, co-immunoprecipitation, phosphorylation assays, myogenic differentiation markers","journal":"Cellular and Molecular Life Sciences","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal approaches for pathway dissection, single lab","pmids":["26211463"],"is_preprint":false},{"year":2015,"finding":"mZnR/GPR39 upregulates neuronal Na+/H+ exchanger (NHE) activity via ERK1/2-dependent pathway, enhancing recovery from intracellular acidification; this signaling is abolished at acidic extracellular pH (6.5), providing a homeostatic pH regulation mechanism.","method":"GPR39 KO neurons, ERK1/2 phosphorylation assay, NHE activity assay, pH manipulation, hippocampal neurons in vitro","journal":"Journal of Neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — KO neurons plus pharmacological dissection with multiple readouts","pmids":["26375174"],"is_preprint":false},{"year":2016,"finding":"Small-molecule GPR39 agonists (LY2784544, GSK2636771) and GPR39-C3 show probe-dependent and pathway-dependent allosteric modulation by physiological zinc concentrations, revealing zinc as an allosteric potentiator of small-molecule GPR39 activation.","method":"β-arrestin recruitment assay (PRESTO-Tango), cAMP assay, Gq signaling assay, allosteric modulation experiments","journal":"Molecular Pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — unbiased screening plus pharmacological characterization, single lab","pmids":["27754899"],"is_preprint":false},{"year":2017,"finding":"GPR39 desensitization occurs via a unique Rho kinase (ROCK)-dependent mechanism: receptor activation induces ROCK-dependent internalization of GPR39; a biased agonist lacking G12/13 activation does not induce desensitization, linking G12/13-ROCK signaling to feedback regulation.","method":"ROCK inhibitor (Y-27632), GFP-tagged GPR39 internalization assay, cAMP, IP1, SRF-RE, β-arrestin recruitment assays, biased agonist comparison","journal":"Biochemical Pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection with receptor localization assay, single lab","pmids":["28619258"],"is_preprint":false},{"year":2017,"finding":"ZnR/GPR39 upregulates basolateral KCC1 in colonocytes to enhance Cl- absorption and reduce cholera toxin-induced fluid loss; this effect requires both dietary Zn2+ and ZnR/GPR39, as both are absent in ZnR/GPR39 KO mice.","method":"ZnR/GPR39 KO mice, cholera toxin fluid secretion model, KCC activity assay, Caco-2 cells, Ussing chambers","journal":"Biochimica et Biophysica Acta - Molecular Basis of Disease","confidence":"High","confidence_rationale":"Tier 2 — KO mouse model plus cell-based ion transport assays","pmids":["28093242"],"is_preprint":false},{"year":2017,"finding":"Zn2+ acting via ZnR/GPR39 activates Gαq-PLC signaling in endothelial cells, promoting cell survival/growth through cAMP and AKT, VEGF-A and PDGF-αR upregulation, and cytoskeletal reorganization; siRNA knockdown of GPR39 abolishes these effects.","method":"GPR39 siRNA, Ca2+ imaging, Gαq-PLC pathway analysis, GPR39 KO endothelial cells, tube formation assay","journal":"American Journal of Physiology - Cell Physiology","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA and KO cells with multiple functional readouts, single lab","pmids":["29351417"],"is_preprint":false},{"year":2017,"finding":"Zn2+ signals via ZnR/GPR39 to induce IL-6 production from skin fibroblasts through GPR39-mediated pathways; ZnT2 transporter is required for Zn2+ release from mast cell granules; wound healing is impaired in GPR39 KO and IL-6 KO mice.","method":"GPR39 KO mice, IL-6 KO mice, ZnT2 KO mice, wound healing model, cytokine measurement","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 2 — multiple KO models with clear phenotypic readout, single lab","pmids":["31346193"],"is_preprint":false},{"year":2017,"finding":"Zinc supplementation via GPR39 upregulates PKCζ, which enhances ZO-1 expression and epithelial integrity in Salmonella-infected Caco-2 cells; siRNA silencing of GPR39 reduces zinc-activated PKCζ and blocks zinc's protective effect on barrier integrity.","method":"siRNA silencing of GPR39 and PKCζ, TEER measurement, Western blot, tight junction protein analysis","journal":"Journal of Nutrition","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal siRNA knockdowns with pathway validation, single lab","pmids":["28515165"],"is_preprint":false},{"year":2018,"finding":"ZnR/GPR39 activates tight junction assembly in intestinal epithelial cells via a PLC-CaMKKβ-AMPK signaling cascade; PLC and CaMKKβ inhibitors abolish GPR39 agonist-induced AMPK activation and tight junction assembly.","method":"GPR39 agonist TC-G 1008, pharmacological inhibitors (PLC, CaMKKβ, AMPK), TEER, Western blot for AMPK phosphorylation, ZO-1 immunofluorescence","journal":"European Journal of Pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological pathway dissection with multiple inhibitors and functional readouts","pmids":["30459126"],"is_preprint":false},{"year":2018,"finding":"ZnR/GPR39 upregulates KCC3 (not KCC4) activity in tamoxifen-resistant breast cancer cells, promoting cell migration and proliferation; KCC3 silencing or ZnR/GPR39 silencing abolishes Zn2+-dependent K+/Cl- co-transport and scratch closure.","method":"siRNA silencing of ZnR/GPR39 and KCC isoforms, NH4+ transport assay (pH surrogate for K+/Cl- transport), scratch closure assay, KCC inhibitor DIOA","journal":"Cell Calcium","confidence":"Medium","confidence_rationale":"Tier 2 — isoform-selective siRNA with transport and migration assays, single lab","pmids":["31146164"],"is_preprint":false},{"year":2016,"finding":"Amyloid-β attenuates mZnR/GPR39-dependent Ca2+ responses, ERK1/2 phosphorylation, and clusterin upregulation in neurons by binding Zn2+ and preventing receptor activation; AKT phosphorylation is not mZnR/GPR39-dependent and is unaffected by Aβ.","method":"GPR39 KO mouse cortical neurons, SHSY-5Y cells, Ca2+ imaging, ERK1/2/AKT phosphorylation, Aβ treatment, mZnR/GPR39 siRNA silencing","journal":"Journal of Neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — KO neurons plus siRNA with multiple pathway-specific readouts","pmids":["27501363"],"is_preprint":false},{"year":2018,"finding":"GPR39 KO osteoblasts have disorganized matrix deposition with abnormally low collagen and high mineral contents; Gpr39-/- mice show reduced Zip13 expression and downregulation of zinc-dependent ADAMTS metalloprotease family members involved in collagen processing.","method":"GPR39 KO mice and primary osteoblast cultures, FTIR spectroscopy, histology, Western blot, Zn transporter expression analysis","journal":"FASEB Journal","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse and cell-autonomous phenotype with mechanistic gene expression analysis","pmids":["29295862"],"is_preprint":false},{"year":2021,"finding":"GPR39 agonism promotes osteoblast differentiation via AMPK-mediated Runx-2 induction; AMPK inhibition by Compound C abolishes TC-G 1008-mediated ALP, osteocalcin, and collagen induction.","method":"GPR39 agonist TC-G 1008, AMPK inhibitor Compound C, ALP activity assay, calcium deposition, Western blot for Runx-2 and AMPK","journal":"Artificial Cells, Nanomedicine, and Biotechnology","confidence":"Medium","confidence_rationale":"Tier 2 — agonist plus inhibitor with differentiation markers, single lab","pmids":["31448639"],"is_preprint":false},{"year":2021,"finding":"GPR39 agonism protects against neuroinflammation post-hypoxic-ischemia via SIRT1/PGC-1α/Nrf2 pathway; GPR39 CRISPR, PGC-1α CRISPR, and SIRT1 inhibitor EX527 abolish TC-G 1008 neuroprotection.","method":"CRISPR knockout of GPR39 and PGC-1α, SIRT1 inhibitor, neonatal rat HIE model, Western blot, immunofluorescence","journal":"Journal of Neuroinflammation","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacological pathway dissection in vivo, single lab","pmids":["34645465"],"is_preprint":false},{"year":2021,"finding":"GPR39-mediated pericyte contraction during reduced coronary perfusion pressure causes capillary constriction leading to 'no reflow' after myocardial infarction; GPR39 KO and GPR39 inhibitor (VC43) treatment reduce no-reflow zones and infarct size.","method":"GPR39 KO mice, coronary occlusion/reperfusion model, GPR39 inhibitor VC43, immunohistochemistry for capillary density and diameter","journal":"American Journal of Physiology - Heart and Circulatory Physiology","confidence":"Medium","confidence_rationale":"Tier 2 — KO plus pharmacological inhibition with anatomical and functional readouts, single lab","pmids":["34623177"],"is_preprint":false},{"year":2021,"finding":"Oral GPR39 agonist (Cpd1324) increases GLP-1 secretion via Gαq and Gαi/o (but not Gαs) signaling in intestinal L cells; this is GPR39-dependent as GPR39 KO organoids do not respond; acute food intake is decreased and GLP-1 levels are elevated in HFD-fed mice.","method":"Bioluminescence resonance energy transfer (BRET) biosensors for G protein activation, mouse/human intestinal organoids, GPR39 KO organoids, plasma hormone measurement","journal":"Molecular Metabolism","confidence":"High","confidence_rationale":"Tier 1-2 — BRET assay for G protein coupling specificity plus KO organoid validation","pmids":["33711555"],"is_preprint":false},{"year":2022,"finding":"Extracellular Zn2+ released from thymocytes after HCT conditioning activates GPR39 on endothelial cells to stimulate BMP4 production, promoting thymic regeneration and T-cell reconstitution; GPR39 agonist enhances thymic function without requiring prior Zn2+ accumulation.","method":"GPR39 KO mice, bone-marrow transplantation model, lineage tracing, small-molecule GPR39 agonist, measurement of BMP4 and recent thymic emigrants","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse plus agonist pharmacology with defined cellular mechanism, single lab","pmids":["35357432"],"is_preprint":false},{"year":2022,"finding":"GPR39 directly binds SUFU (suppressor of fused), an endogenous inhibitor of the Sonic Hedgehog pathway; overexpression or activation of GPR39 suppresses basal and ligand-dependent GLI1 activation and EC migration; GPR39 KO enhances revascularization in diabetic hindlimb ischemia.","method":"Co-immunoprecipitation of GPR39 and SUFU, adenoviral GPR39 overexpression, siRNA knockdown, SUFU overexpression rescue, GPR39 KO mouse ischemia model","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 — direct binding (Co-IP) plus epistasis (SUFU rescue) plus KO in vivo, single lab","pmids":["36574661"],"is_preprint":false},{"year":2024,"finding":"GPR39 is an evolutionarily conserved receptor for bile acids, particularly 3-O-sulfated lithocholic acids; GPR39 is sufficient for bile acid-induced Ca2+ elevation in cultured cells and mediates Ca2+ elevation and necrosis in pancreatic acinar cells; GPR39 KO mice show significantly reduced bile acid-induced acute pancreatitis.","method":"Cell-line Ca2+ assay with GPR39 expression, pancreatic acinar cell Ca2+ and necrosis assays, GPR39 KO mice in bile acid-induced pancreatitis model","journal":"Science Advances","confidence":"High","confidence_rationale":"Tier 1-2 — receptor sufficiency assay plus genetic KO in vivo disease model","pmids":["38306436"],"is_preprint":false},{"year":2024,"finding":"Bone-marrow macrophage-derived GPNMB binds directly to GPR39 as a ligand; GPR39 mediates GPNMB's beneficial effects on post-MI cardiac repair; GPR39 KO abrogates the protective effects of GPNMB on myocyte contraction and fibroblast activation.","method":"Lineage tracing, bone-marrow transplantation, genetic loss-of-function (GPNMB KO, GPR39 KO), viral GPNMB delivery, single-cell transcriptomics, receptor binding identification","journal":"Nature Cardiovascular Research","confidence":"High","confidence_rationale":"Tier 2 — identification of GPNMB as GPR39 ligand with genetic epistasis (GPR39 KO abrogates GPNMB effects), multiple complementary methods","pmids":["39455836"],"is_preprint":false},{"year":2024,"finding":"ZnR/GPR39 modulates hepatic insulin receptor signaling: KO mice show elevated insulin receptor expression and AKT activation, higher fasting glucose, hepatic lipid accumulation, increased OCR and ROS, and marked liver fibrosis with elevated collagen; ZnR/GPR39 also regulates ERK1/2 phosphorylation in liver.","method":"GPR39 KO mice, Western blot (insulin receptor, AKT, ERK1/2), hepatic OCR/ROS measurement, LPS-induced ALI model, serum cytokines, collagen staining","journal":"Redox Biology","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with multiple metabolic and signaling readouts, single lab","pmids":["39514940"],"is_preprint":false},{"year":2021,"finding":"GPR39 promotes cardiac hypertrophy by inhibiting AMPK, leading to mTOR and S6K1 activation and increased de novo protein synthesis; adeno-associated virus GPR39 knockdown suppresses TAC-induced hypertrophy, and rapamycin blocks GPR39 overexpression-induced protein synthesis.","method":"AAV9-mediated GPR39 knockdown, adenovirus GPR39 overexpression, TAC mouse model, mTOR inhibitor rapamycin, Western blot for AMPK/mTOR/S6K1, cardiomyocyte size measurement","journal":"Cell Biology International","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo gene manipulation plus pharmacological mTOR inhibition, single lab","pmids":["33554444"],"is_preprint":false}],"current_model":"GPR39 is a constitutively active, Zn2+-sensing class A GPCR that couples to Gαq (triggering PLC-IP3-Ca2+ and downstream ERK1/2, AKT, mTOR signaling), Gαs (cAMP), and Gα12/13 (RhoA-SRE transcription); Zn2+ binds through His17/His19 in the N-terminal domain, with Asp313 in ECL3 functioning as both a tethered inverse agonist and pH sensor, and a non-conserved disulfide bridge (Cys11–Cys191) dampening receptor activation; downstream, GPR39 regulates KCC2 and KCC1/3 ion cotransporter activity in neurons and epithelia, controls colonocyte proliferation/differentiation and tight junction integrity, promotes thymic regeneration via BMP4, participates in the Hedgehog pathway by binding SUFU, can be activated by bile acids (particularly 3-O-sulfated lithocholic acids) and by macrophage-derived GPNMB, and undergoes Rho kinase (ROCK)-dependent desensitization and internalization."},"narrative":{"teleology":[{"year":1997,"claim":"Cloning of GPR39 established it as a novel orphan GPCR within the GHS-R/neurotensin receptor family, setting the stage for ligand identification and functional characterization.","evidence":"cDNA cloning, genomic hybridization, and sequence analysis in human tissues","pmids":["9441746"],"confidence":"Medium","gaps":["No ligand or signaling pathway identified","Functional role entirely unknown","Expression pattern only broadly characterized"]},{"year":2007,"claim":"Identification of Zn²⁺ as the endogenous GPR39 agonist resolved the orphan receptor problem and revealed multi-pathway G protein coupling (Gαq–PLC, Gαs–cAMP, Gα13–RhoA–SRE), while definitively excluding obestatin as a ligand.","evidence":"HPLC fractionation of fetal bovine serum with ICP-MS identification, cell-based IP turnover, cAMP, β-arrestin, and reporter assays; pharmacological pathway dissection with PLC inhibitor and pertussis toxin","pmids":["16959833","17054911","17885920","18180304"],"confidence":"High","gaps":["Zn²⁺ binding site on receptor not yet mapped","Physiological contexts of each G protein pathway unclear","In vivo relevance of zinc sensing not demonstrated"]},{"year":2008,"claim":"Systematic mutagenesis defined the structural determinants of GPR39 activation: His17/His19 as the Zn²⁺ coordination site, Asp313 as a tethered inverse agonist, and a non-conserved disulfide (Cys11–Cys191) as a negative modulator of receptor sensitivity.","evidence":"Alanine-scanning and cysteine mutagenesis with inositol phosphate assays, TCEP reduction, and free sulfhydryl labeling","pmids":["18588883","18693759"],"confidence":"High","gaps":["No crystal or cryo-EM structure available","Contribution of each residue to G protein selectivity unknown","Mechanism by which Asp313 enforces inverse agonism at the structural level unresolved"]},{"year":2010,"claim":"Establishing GPR39 as the molecular identity of the zinc-sensing receptor (ZnR) in keratinocytes and colonocytes linked it to physiological processes including wound healing and epithelial cytoprotection.","evidence":"siRNA silencing of GPR39 abolishes Zn²⁺-dependent Ca²⁺ responses, MAP kinase activation, and scratch wound closure in keratinocytes; GPR39 KO mouse colon validates colonocyte signaling","pmids":["20522546","22545109"],"confidence":"High","gaps":["In vivo wound healing phenotype in GPR39 KO mice not yet tested at this stage","Relative contribution of GPR39 vs. other zinc importers to zinc sensing unclear"]},{"year":2011,"claim":"Discovery that synaptically released Zn²⁺ activates postsynaptic GPR39 to upregulate KCC2 and shift GABAergic inhibition established GPR39 as a neuronal zinc sensor regulating excitation-inhibition balance.","evidence":"GPR39 KO and ZnT3 KO mice, hippocampal slice electrophysiology, KCC2 surface expression assay, EGABA measurement","pmids":["21900570"],"confidence":"High","gaps":["Whether GPR39 loss contributes to neuropsychiatric disease in humans unknown","Role in other brain regions beyond hippocampal mossy fibers not explored"]},{"year":2012,"claim":"Identification of Asp313 as a pH sensor (distinct from the Zn²⁺-binding His17/His19) revealed that GPR39 integrates two extracellular signals—zinc concentration and pH—to modulate downstream ERK1/2 and AKT activation.","evidence":"Site-directed mutagenesis of Asp313, His17, His19 with Ca²⁺ imaging and ERK/AKT/NHE activity at varying pH","pmids":["22879599"],"confidence":"High","gaps":["Whether pH and Zn²⁺ bind the same or distinct receptor conformations is unresolved","In vivo relevance of pH sensing (e.g., in ischemic tissue) not tested"]},{"year":2014,"claim":"Multiple studies converged to show GPR39 governs colonocyte proliferation, differentiation, and tight junction integrity via ERK1/2–AKT–mTOR, and participates in Hedgehog pathway regulation by modulating Gli transcription factor activity.","evidence":"siRNA/KO in colonocytes measuring differentiation markers, TEER, and tight junction proteins; reciprocal gain/loss-of-function in Hh reporter assays","pmids":["24967969","24633354"],"confidence":"High","gaps":["Direct GPR39–SUFU interaction not yet demonstrated at this stage","Relationship between Zn²⁺ and Hedgehog modulation not clarified","Whether epithelial barrier effects are cell-autonomous in vivo unknown"]},{"year":2015,"claim":"GPR39 KO mice showed dramatically enhanced seizure susceptibility, establishing the Gαq/PLC/ERK–KCC2 axis as physiologically critical for neuronal inhibitory tone and revealing GPR39 as a seizure susceptibility modifier.","evidence":"GPR39 KO mice subjected to kainic acid, hippocampal electrophysiology, KCC2 surface expression, PLC/ERK inhibitors","pmids":["25562657"],"confidence":"High","gaps":["Human genetic association with epilepsy not demonstrated","Therapeutic potential of GPR39 agonists in seizure models not tested at this point"]},{"year":2017,"claim":"GPR39 desensitization was shown to proceed through a unique ROCK-dependent internalization mechanism downstream of Gα12/13, distinguishing it from canonical GRK/β-arrestin–mediated GPCR desensitization, and colonic KCC1 regulation linked GPR39 to chloride absorption and diarrheal disease protection.","evidence":"ROCK inhibitor Y-27632 and biased agonist experiments for desensitization; GPR39 KO mice in cholera toxin fluid secretion model with Ussing chamber ion transport","pmids":["28619258","28093242"],"confidence":"Medium","gaps":["Whether ROCK-dependent desensitization occurs for all GPR39-expressing cell types unknown","Structural basis for biased agonism at GPR39 not defined"]},{"year":2021,"claim":"GPR39 was linked to cardiac hypertrophy (via AMPK inhibition–mTOR activation), neuroprotection (via SIRT1/PGC-1α/Nrf2), GLP-1 secretion from intestinal L cells (via Gαq/Gαi/o), and thymic regeneration (via BMP4), greatly expanding its physiological scope beyond zinc sensing.","evidence":"AAV9-mediated knockdown in TAC model; CRISPR KO in neonatal HIE model; BRET G protein biosensors and GPR39 KO organoids; GPR39 KO mice in bone marrow transplant model","pmids":["33554444","34645465","33711555","35357432"],"confidence":"Medium","gaps":["Ligand identity driving GPR39 in cardiac hypertrophy unclear (Zn²⁺ vs. other)","Whether GPR39 agonists are therapeutically viable in these contexts untested in humans","Relative contribution of Gαq vs. Gαi/o to GLP-1 secretion not fully dissected"]},{"year":2022,"claim":"Direct physical interaction between GPR39 and SUFU provided a mechanistic basis for GPR39's suppression of Hedgehog/GLI1 signaling, and GPR39 KO enhanced revascularization, placing GPR39 at the intersection of GPCR and Hedgehog pathways.","evidence":"Co-immunoprecipitation of GPR39 and SUFU, SUFU overexpression rescue, GPR39 KO in diabetic hindlimb ischemia model","pmids":["36574661"],"confidence":"High","gaps":["Whether the GPR39–SUFU interaction is zinc-dependent unknown","Structural basis of GPR39–SUFU binding uncharacterized","Relevance to developmental Hedgehog signaling not tested"]},{"year":2024,"claim":"GPR39 was deorphanized further as a receptor for 3-O-sulfated bile acids (mediating pancreatitis) and for macrophage-derived GPNMB (mediating post-MI cardiac repair), establishing GPR39 as a multi-ligand receptor with tissue-specific disease roles.","evidence":"GPR39-expressing cell Ca²⁺ sufficiency assays, GPR39 KO mice in bile acid–induced pancreatitis and post-MI models, genetic epistasis with GPNMB KO","pmids":["38306436","39455836"],"confidence":"High","gaps":["How Zn²⁺, bile acids, and GPNMB compete or cooperate at the receptor binding site is unknown","Structural basis for multi-ligand recognition not resolved","Whether bile acid and GPNMB signals use the same or distinct G protein pathways through GPR39 is undefined"]},{"year":null,"claim":"No high-resolution structure of GPR39 exists, and the mechanisms by which three chemically distinct ligands (Zn²⁺, sulfated bile acids, GPNMB) activate the same receptor—potentially through distinct binding sites and biased signaling—remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No cryo-EM or crystal structure","Allosteric vs. orthosteric binding of each ligand class not mapped","In vivo hierarchy of ligands in different tissues unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,2,4,36,37]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,5,7,8]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2,6,11,17,33,36,37]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[12,35]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[34]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[8,17,22,27]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[36,37,39]}],"complexes":[],"partners":["SUFU","GPNMB","CASR","PKIB","HTR1A","GALR1"],"other_free_text":[]},"mechanistic_narrative":"GPR39 is a constitutively active class A GPCR that functions as a zinc-sensing receptor (ZnR) and integrates extracellular Zn²⁺, bile acid, and GPNMB signals into diverse intracellular cascades across epithelial, neuronal, endothelial, and immune cell types. Zn²⁺ binds via His17/His19 in the N-terminal domain while Asp313 in ECL3 serves as both a tethered inverse agonist and pH sensor; the receptor couples to Gαq (PLC–IP3–Ca²⁺–ERK1/2), Gαs (cAMP), and Gα12/13 (RhoA–SRE transcription), with desensitization proceeding through a ROCK-dependent internalization pathway [PMID:16959833, PMID:18588883, PMID:22879599, PMID:28619258]. In neurons, synaptically released Zn²⁺ activates GPR39 to upregulate KCC2 surface expression via Gαq/PLC/ERK1/2, shifting GABA_A reversal potential and enhancing inhibitory tone, while in colonocytes and other epithelia GPR39 drives tight junction assembly, ion cotransporter (KCC1/3, NHE) regulation, and proliferation/differentiation through ERK1/2–AKT–mTOR signaling [PMID:21900570, PMID:24967969, PMID:28093242]. GPR39 also serves as a receptor for 3-O-sulfated lithocholic acids mediating bile acid–induced Ca²⁺ signaling and pancreatic acinar cell injury, and for macrophage-derived GPNMB promoting post-myocardial infarction cardiac repair [PMID:38306436, PMID:39455836]."},"prefetch_data":{"uniprot":{"accession":"O43194","full_name":"G-protein coupled receptor 39","aliases":[],"length_aa":453,"mass_kda":51.3,"function":"Zinc-sensing receptor that can sense changes in extracellular Zn(2+), mediate Zn(2+) signal transmission, and participates in the regulation of numerous physiological processes including glucose homeostasis regulation, gastrointestinal mobility, hormone secretion and cell death (PubMed:18180304). Activation by Zn(2+) in keratinocytes increases the intracellular concentration of Ca(2+) and activates the ERK/MAPK and PI3K/AKT signaling pathways leading to epithelial repair (PubMed:20522546). Plays an essential role in normal wound healing by inducing the production of cytokines including the major inflammatory cytokine IL6 via the PKC/MAPK/CEBPB pathway (By similarity). Regulates adipose tissue metabolism, especially lipolysis, and regulates the function of lipases, such as hormone-sensitive lipase and adipose triglyceride lipase (By similarity). Plays a role in the inhibition of cell death and protects against oxidative, endoplasmic reticulum and mitochondrial stress by inducing secretion of the cytoprotective pigment epithelium-derived growth factor (PEDF) and probably other protective transcripts in a GNA13/RHOA/SRE-dependent manner (PubMed:18180304). Forms dynamic heteroreceptor complexes with HTR1A and GALR1 depending on cell type or specific physiological states, resulting in signaling diversity: HTR1A-GPR39 shows additive increase in signaling along the serum response element (SRE) and NF-kappa-B pathways while GALR1 acts as an antagonist blocking SRE (PubMed:26365466)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/O43194/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GPR39","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GPR39","total_profiled":1310},"omim":[{"mim_id":"610450","title":"LY6/PLAUR DOMAIN-CONTAINING PROTEIN 1; LYPD1","url":"https://www.omim.org/entry/610450"},{"mim_id":"605353","title":"GHRELIN; GHRL","url":"https://www.omim.org/entry/605353"},{"mim_id":"602886","title":"G PROTEIN-COUPLED RECEPTOR 39; GPR39","url":"https://www.omim.org/entry/602886"},{"mim_id":"602885","title":"MOTILIN RECEPTOR; MLNR","url":"https://www.omim.org/entry/602885"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":6.3}],"url":"https://www.proteinatlas.org/search/GPR39"},"hgnc":{"alias_symbol":["ZnR"],"prev_symbol":[]},"alphafold":{"accession":"O43194","domains":[{"cath_id":"1.20.1070.10","chopping":"26-182_209-254_272-361","consensus_level":"high","plddt":91.4576,"start":26,"end":361}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43194","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43194-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43194-F1-predicted_aligned_error_v6.png","plddt_mean":76.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GPR39","jax_strain_url":"https://www.jax.org/strain/search?query=GPR39"},"sequence":{"accession":"O43194","fasta_url":"https://rest.uniprot.org/uniprotkb/O43194.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43194/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43194"}},"corpus_meta":[{"pmid":"16959833","id":"PMC_16959833","title":"GPR39 signaling is stimulated by zinc ions but not by obestatin.","date":"2006","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16959833","citation_count":344,"is_preprint":false},{"pmid":"9441746","id":"PMC_9441746","title":"Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9441746","citation_count":240,"is_preprint":false},{"pmid":"17054911","id":"PMC_17054911","title":"Obestatin does not activate orphan G protein-coupled receptor GPR39.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17054911","citation_count":192,"is_preprint":false},{"pmid":"17030183","id":"PMC_17030183","title":"Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse.","date":"2006","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17030183","citation_count":135,"is_preprint":false},{"pmid":"17095592","id":"PMC_17095592","title":"Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39.","date":"2006","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17095592","citation_count":121,"is_preprint":false},{"pmid":"21900570","id":"PMC_21900570","title":"Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR/GPR39 receptor.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21900570","citation_count":116,"is_preprint":false},{"pmid":"20812023","id":"PMC_20812023","title":"GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions.","date":"2010","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/20812023","citation_count":101,"is_preprint":false},{"pmid":"16708020","id":"PMC_16708020","title":"GPR39 receptor expression in the mouse brain.","date":"2006","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/16708020","citation_count":98,"is_preprint":false},{"pmid":"20522546","id":"PMC_20522546","title":"Zinc released from injured cells is acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20522546","citation_count":96,"is_preprint":false},{"pmid":"29389900","id":"PMC_29389900","title":"The Zinc Sensing Receptor, ZnR/GPR39, in Health and Disease.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29389900","citation_count":88,"is_preprint":false},{"pmid":"29351417","id":"PMC_29351417","title":"Zinc regulates vascular endothelial cell activity through zinc-sensing receptor ZnR/GPR39.","date":"2017","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29351417","citation_count":81,"is_preprint":false},{"pmid":"17885920","id":"PMC_17885920","title":"Isolation of Zn2+ as an endogenous agonist of GPR39 from fetal bovine serum.","date":"2007","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/17885920","citation_count":81,"is_preprint":false},{"pmid":"17488974","id":"PMC_17488974","title":"GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue.","date":"2007","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/17488974","citation_count":78,"is_preprint":false},{"pmid":"25609596","id":"PMC_25609596","title":"GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampus.","date":"2014","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25609596","citation_count":76,"is_preprint":false},{"pmid":"24967969","id":"PMC_24967969","title":"The zinc sensing receptor, ZnR/GPR39, controls proliferation and differentiation of colonocytes and thereby tight junction formation in the colon.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24967969","citation_count":76,"is_preprint":false},{"pmid":"24333148","id":"PMC_24333148","title":"The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims.","date":"2013","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24333148","citation_count":67,"is_preprint":false},{"pmid":"25562657","id":"PMC_25562657","title":"Homeostatic regulation of KCC2 activity by the zinc receptor mZnR/GPR39 during seizures.","date":"2015","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/25562657","citation_count":65,"is_preprint":false},{"pmid":"18180304","id":"PMC_18180304","title":"The constitutively active orphan G-protein-coupled receptor GPR39 protects from cell death by increasing secretion of pigment epithelium-derived growth factor.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18180304","citation_count":63,"is_preprint":false},{"pmid":"23089648","id":"PMC_23089648","title":"The role of the GPR39 receptor in zinc deficient-animal model of depression.","date":"2012","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/23089648","citation_count":58,"is_preprint":false},{"pmid":"18588883","id":"PMC_18588883","title":"Molecular mechanism of Zn2+ agonism in the extracellular domain of GPR39.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/18588883","citation_count":55,"is_preprint":false},{"pmid":"24633354","id":"PMC_24633354","title":"Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39.","date":"2014","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/24633354","citation_count":51,"is_preprint":false},{"pmid":"30459126","id":"PMC_30459126","title":"An agonist of a zinc-sensing receptor GPR39 enhances tight junction assembly in intestinal epithelial cells via an AMPK-dependent mechanism.","date":"2018","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30459126","citation_count":46,"is_preprint":false},{"pmid":"27754899","id":"PMC_27754899","title":"Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc.","date":"2016","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27754899","citation_count":44,"is_preprint":false},{"pmid":"32553391","id":"PMC_32553391","title":"GPR39 protects against corticosterone-induced neuronal injury in hippocampal cells through the CREB-BDNF signaling pathway.","date":"2020","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/32553391","citation_count":44,"is_preprint":false},{"pmid":"32259211","id":"PMC_32259211","title":"Zinc ameliorates human aortic valve calcification through GPR39 mediated ERK1/2 signalling pathway.","date":"2021","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/32259211","citation_count":44,"is_preprint":false},{"pmid":"17371481","id":"PMC_17371481","title":"The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus.","date":"2007","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17371481","citation_count":43,"is_preprint":false},{"pmid":"31576658","id":"PMC_31576658","title":"microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31576658","citation_count":43,"is_preprint":false},{"pmid":"21784784","id":"PMC_21784784","title":"Deficiency of the GPR39 receptor is associated with obesity and altered adipocyte metabolism.","date":"2011","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/21784784","citation_count":42,"is_preprint":false},{"pmid":"22545109","id":"PMC_22545109","title":"Zinc sensing receptor signaling, mediated by GPR39, reduces butyrate-induced cell death in HT29 colonocytes via upregulation of clusterin.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22545109","citation_count":41,"is_preprint":false},{"pmid":"34645465","id":"PMC_34645465","title":"Activation of GPR39 with TC-G 1008 attenuates neuroinflammation via SIRT1/PGC-1α/Nrf2 pathway post-neonatal hypoxic-ischemic injury in rats.","date":"2021","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/34645465","citation_count":41,"is_preprint":false},{"pmid":"27377730","id":"PMC_27377730","title":"The zinc sensing receptor, ZnR/GPR39, triggers metabotropic calcium signalling in colonocytes and regulates occludin recovery in experimental colitis.","date":"2016","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27377730","citation_count":41,"is_preprint":false},{"pmid":"33918078","id":"PMC_33918078","title":"The Zinc-Sensing Receptor GPR39 in Physiology and as a Pharmacological Target.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33918078","citation_count":39,"is_preprint":false},{"pmid":"25490458","id":"PMC_25490458","title":"GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?","date":"2014","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/25490458","citation_count":39,"is_preprint":false},{"pmid":"34623177","id":"PMC_34623177","title":"Mechanism and potential treatment of the \"no reflow\" phenomenon after acute myocardial infarction: role of pericytes and GPR39.","date":"2021","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34623177","citation_count":39,"is_preprint":false},{"pmid":"31346193","id":"PMC_31346193","title":"Mast cells play role in wound healing through the ZnT2/GPR39/IL-6 axis.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31346193","citation_count":39,"is_preprint":false},{"pmid":"25313322","id":"PMC_25313322","title":"Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.","date":"2014","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/25313322","citation_count":39,"is_preprint":false},{"pmid":"22884904","id":"PMC_22884904","title":"GI functions of GPR39: novel biology.","date":"2012","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22884904","citation_count":37,"is_preprint":false},{"pmid":"28515165","id":"PMC_28515165","title":"Zinc Supplementation, via GPR39, Upregulates PKCζ to Protect Intestinal Barrier Integrity in Caco-2 Cells Challenged by Salmonella enterica Serovar Typhimurium.","date":"2017","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/28515165","citation_count":37,"is_preprint":false},{"pmid":"22992743","id":"PMC_22992743","title":"The obestatin/GPR39 system is up-regulated by muscle injury and functions as an autocrine regenerative system.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22992743","citation_count":35,"is_preprint":false},{"pmid":"27235821","id":"PMC_27235821","title":"Potential antidepressant-like properties of the TC G-1008, a GPR39 (zinc receptor) agonist.","date":"2016","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/27235821","citation_count":35,"is_preprint":false},{"pmid":"27044837","id":"PMC_27044837","title":"A possible significant role of zinc and GPR39 zinc sensing receptor in Alzheimer disease and epilepsy.","date":"2016","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/27044837","citation_count":35,"is_preprint":false},{"pmid":"32325008","id":"PMC_32325008","title":"GPR39 Overexpression in OSCC Promotes YAP-Sustained Malignant Progression.","date":"2020","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/32325008","citation_count":35,"is_preprint":false},{"pmid":"31551684","id":"PMC_31551684","title":"Long-Term Effects of Zinc Deficiency and Zinc Supplementation on Developmental Seizure-Induced Brain Damage and the Underlying GPR39/ZnT-3 and MBP Expression in the Hippocampus.","date":"2019","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31551684","citation_count":35,"is_preprint":false},{"pmid":"23474197","id":"PMC_23474197","title":"GPR39 up-regulation after selective antidepressants.","date":"2013","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/23474197","citation_count":34,"is_preprint":false},{"pmid":"24264723","id":"PMC_24264723","title":"The ZnR/GPR39 interacts with the CaSR to enhance signaling in prostate and salivary epithelia.","date":"2014","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24264723","citation_count":33,"is_preprint":false},{"pmid":"26365466","id":"PMC_26365466","title":"The zinc binding receptor GPR39 interacts with 5-HT1A and GalR1 to form dynamic heteroreceptor complexes with signaling diversity.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26365466","citation_count":33,"is_preprint":false},{"pmid":"26524639","id":"PMC_26524639","title":"GPR39 activates proliferation and differentiation of porcine intramuscular preadipocytes through targeting the PI3K/AKT cell signaling pathway.","date":"2015","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/26524639","citation_count":33,"is_preprint":false},{"pmid":"21470317","id":"PMC_21470317","title":"GPR39, a receptor of the ghrelin receptor family, plays a role in the regulation of glucose homeostasis in a mouse model of early onset diet-induced obesity.","date":"2011","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21470317","citation_count":31,"is_preprint":false},{"pmid":"28045522","id":"PMC_28045522","title":"Model-Based Discovery of Synthetic Agonists for the Zn2+-Sensing G-Protein-Coupled Receptor 39 (GPR39) Reveals Novel Biological Functions.","date":"2017","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28045522","citation_count":31,"is_preprint":false},{"pmid":"25827929","id":"PMC_25827929","title":"Study of antidepressant drugs in GPR39 (zinc receptor⁻/⁻) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists.","date":"2015","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/25827929","citation_count":31,"is_preprint":false},{"pmid":"28199213","id":"PMC_28199213","title":"The zinc sensing receptor, ZnR/GPR39, in health and disease.","date":"2017","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/28199213","citation_count":30,"is_preprint":false},{"pmid":"35357432","id":"PMC_35357432","title":"Activation of the zinc-sensing receptor GPR39 promotes T-cell reconstitution after hematopoietic cell transplant in mice.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/35357432","citation_count":30,"is_preprint":false},{"pmid":"28093242","id":"PMC_28093242","title":"The Zn2+-sensing receptor, ZnR/GPR39, upregulates colonocytic Cl- absorption, via basolateral KCC1, and reduces fluid loss.","date":"2017","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/28093242","citation_count":29,"is_preprint":false},{"pmid":"26481532","id":"PMC_26481532","title":"Up-regulation of the GPR39 Zn2+-sensing receptor and CREB/BDNF/TrkB pathway after chronic but not acute antidepressant treatment in the frontal cortex of zinc-deficient mice.","date":"2015","source":"Pharmacological reports : PR","url":"https://pubmed.ncbi.nlm.nih.gov/26481532","citation_count":29,"is_preprint":false},{"pmid":"25917396","id":"PMC_25917396","title":"Investigation of the GPR39 zinc receptor following inhibition of monoaminergic neurotransmission and potentialization of glutamatergic neurotransmission.","date":"2015","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/25917396","citation_count":28,"is_preprint":false},{"pmid":"21352519","id":"PMC_21352519","title":"Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.","date":"2011","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21352519","citation_count":28,"is_preprint":false},{"pmid":"30419533","id":"PMC_30419533","title":"Long-lasting antidepressant-like activity of the GPR39 zinc receptor agonist TC-G 1008.","date":"2018","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/30419533","citation_count":27,"is_preprint":false},{"pmid":"18977259","id":"PMC_18977259","title":"Is GPR39 the natural receptor of obestatin?","date":"2008","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/18977259","citation_count":26,"is_preprint":false},{"pmid":"27501363","id":"PMC_27501363","title":"Amyloid β attenuates metabotropic zinc sensing receptor, mZnR/GPR39, dependent Ca2+ , ERK1/2 and Clusterin signaling in neurons.","date":"2016","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27501363","citation_count":26,"is_preprint":false},{"pmid":"18693759","id":"PMC_18693759","title":"A second disulfide bridge from the N-terminal domain to extracellular loop 2 dampens receptor activity in GPR39.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18693759","citation_count":26,"is_preprint":false},{"pmid":"32504391","id":"PMC_32504391","title":"Protective Effects of Co-administration of Zinc and Selenium Against Streptozotocin-Induced Alzheimer's Disease: Behavioral, Mitochondrial Oxidative Stress, and GPR39 Expression Alterations in Rats.","date":"2020","source":"Neurotoxicity research","url":"https://pubmed.ncbi.nlm.nih.gov/32504391","citation_count":26,"is_preprint":false},{"pmid":"31272355","id":"PMC_31272355","title":"Zinc-mediated Neurotransmission in Alzheimer's Disease: A Potential Role of the GPR39 in Dementia.","date":"2020","source":"Current neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31272355","citation_count":25,"is_preprint":false},{"pmid":"34360964","id":"PMC_34360964","title":"Role of GPR39 in Neurovascular Homeostasis and Disease.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34360964","citation_count":25,"is_preprint":false},{"pmid":"26375174","id":"PMC_26375174","title":"Regulation of neuronal pH by the metabotropic Zn(2+)-sensing Gq-coupled receptor, mZnR/GPR39.","date":"2015","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26375174","citation_count":25,"is_preprint":false},{"pmid":"31202806","id":"PMC_31202806","title":"Activation of GPR39 with the agonist TC-G 1008 ameliorates ox-LDL-induced attachment of monocytes to endothelial cells.","date":"2019","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31202806","citation_count":24,"is_preprint":false},{"pmid":"25604641","id":"PMC_25604641","title":"GPR39 marks specific cells within the sebaceous gland and contributes to skin wound healing.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25604641","citation_count":24,"is_preprint":false},{"pmid":"22164158","id":"PMC_22164158","title":"β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia.","date":"2011","source":"International journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/22164158","citation_count":24,"is_preprint":false},{"pmid":"33632103","id":"PMC_33632103","title":"Interaction between Zinc, GPR39, BDNF and Neuropeptides in Depression.","date":"2021","source":"Current neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33632103","citation_count":23,"is_preprint":false},{"pmid":"29295862","id":"PMC_29295862","title":"Perturbed bone composition and integrity with disorganized osteoblast function in zinc receptor/Gpr39-deficient mice.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/29295862","citation_count":23,"is_preprint":false},{"pmid":"26211463","id":"PMC_26211463","title":"β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells.","date":"2015","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/26211463","citation_count":23,"is_preprint":false},{"pmid":"33549699","id":"PMC_33549699","title":"Interaction between zinc, the GPR39 zinc receptor and the serotonergic system in depression.","date":"2021","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/33549699","citation_count":22,"is_preprint":false},{"pmid":"22879599","id":"PMC_22879599","title":"Extracellular pH regulates zinc signaling via an Asp residue of the zinc-sensing receptor (ZnR/GPR39).","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22879599","citation_count":22,"is_preprint":false},{"pmid":"38306436","id":"PMC_38306436","title":"Discoveries of GPR39 as an evolutionarily conserved receptor for bile acids and of its involvement in biliary acute pancreatitis.","date":"2024","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/38306436","citation_count":21,"is_preprint":false},{"pmid":"28619258","id":"PMC_28619258","title":"Rho kinase-dependent desensitization of GPR39; a unique mechanism of GPCR downregulation.","date":"2017","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28619258","citation_count":21,"is_preprint":false},{"pmid":"31448639","id":"PMC_31448639","title":"GPR39 agonist TC-G 1008 promotes osteoblast differentiation and mineralization in MC3T3-E1 cells.","date":"2019","source":"Artificial cells, nanomedicine, and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/31448639","citation_count":21,"is_preprint":false},{"pmid":"26716511","id":"PMC_26716511","title":"The role of the obestatin/GPR39 system in human gastric adenocarcinomas.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26716511","citation_count":21,"is_preprint":false},{"pmid":"26720709","id":"PMC_26720709","title":"Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26720709","citation_count":21,"is_preprint":false},{"pmid":"31539553","id":"PMC_31539553","title":"The protective effects of the GPR39 agonist TC-G 1008 against TNF-α-induced inflammation in human fibroblast-like synoviocytes (FLSs).","date":"2019","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31539553","citation_count":20,"is_preprint":false},{"pmid":"33554444","id":"PMC_33554444","title":"GPR39 promotes cardiac hypertrophy by regulating the AMPK-mTOR pathway and protein synthesis.","date":"2021","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/33554444","citation_count":20,"is_preprint":false},{"pmid":"34692987","id":"PMC_34692987","title":"GPR39 localization in the aging human brain and correlation of expression and polymorphism with vascular cognitive impairment.","date":"2021","source":"Alzheimer's & dementia (New York, N. Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/34692987","citation_count":20,"is_preprint":false},{"pmid":"36574661","id":"PMC_36574661","title":"Inhibition of GPR39 restores defects in endothelial cell-mediated neovascularization under the duress of chronic hyperglycemia: Evidence for regulatory roles of the sonic hedgehog signaling axis.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36574661","citation_count":19,"is_preprint":false},{"pmid":"30610192","id":"PMC_30610192","title":"Modulation of Gpr39, a G-protein coupled receptor associated with alcohol use in non-human primates, curbs ethanol intake in mice.","date":"2019","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30610192","citation_count":19,"is_preprint":false},{"pmid":"29802348","id":"PMC_29802348","title":"Enhanced ZnR/GPR39 Activity in Breast Cancer, an Alternative Trigger of Signaling Leading to Cell Growth.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29802348","citation_count":18,"is_preprint":false},{"pmid":"33711555","id":"PMC_33711555","title":"Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist.","date":"2021","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33711555","citation_count":17,"is_preprint":false},{"pmid":"39455836","id":"PMC_39455836","title":"Bone-marrow macrophage-derived GPNMB protein binds to orphan receptor GPR39 and plays a critical role in cardiac repair.","date":"2024","source":"Nature cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/39455836","citation_count":17,"is_preprint":false},{"pmid":"31146164","id":"PMC_31146164","title":"ZnR/GPR39 upregulation of K+/Cl--cotransporter 3 in tamoxifen resistant breast cancer cells.","date":"2019","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/31146164","citation_count":17,"is_preprint":false},{"pmid":"26112416","id":"PMC_26112416","title":"GPR39 receptors and actions of trace metals on pancreatic beta cell function and glucose homoeostasis.","date":"2015","source":"Acta diabetologica","url":"https://pubmed.ncbi.nlm.nih.gov/26112416","citation_count":17,"is_preprint":false},{"pmid":"24900608","id":"PMC_24900608","title":"Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example.","date":"2013","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/24900608","citation_count":17,"is_preprint":false},{"pmid":"31776425","id":"PMC_31776425","title":"Zn2+ stimulates salivary secretions via metabotropic zinc receptor ZnR/GPR39 in human salivary gland cells.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31776425","citation_count":16,"is_preprint":false},{"pmid":"24869658","id":"PMC_24869658","title":"Protein kinase inhibitor β enhances the constitutive activity of G-protein-coupled zinc receptor GPR39.","date":"2014","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24869658","citation_count":15,"is_preprint":false},{"pmid":"34743948","id":"PMC_34743948","title":"miR-182 mediated the inhibitory effects of NF-κB on the GPR39/CREB/BDNF pathway in the hippocampus of mice with depressive-like behaviors.","date":"2021","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/34743948","citation_count":14,"is_preprint":false},{"pmid":"27106635","id":"PMC_27106635","title":"Changes in obestatin gene and GPR39 receptor expression in peripheral tissues of rat models of obesity, type 1 and type 2 diabetes.","date":"2016","source":"Journal of diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/27106635","citation_count":14,"is_preprint":false},{"pmid":"38485864","id":"PMC_38485864","title":"GPR39 Agonist TC-G 1008 Promoted Mitochondrial Biogenesis and Improved Antioxidative Capability via CREB/PGC-1α Pathway Following Intracerebral Hemorrhage in Mice.","date":"2024","source":"Translational stroke research","url":"https://pubmed.ncbi.nlm.nih.gov/38485864","citation_count":13,"is_preprint":false},{"pmid":"17239877","id":"PMC_17239877","title":"Molecular characterization of sequence and expression of chicken GPR39.","date":"2006","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17239877","citation_count":13,"is_preprint":false},{"pmid":"31678046","id":"PMC_31678046","title":"Agonism of GPR39 displays protective effects against advanced glycation end-product (AGE)-induced degradation of extracellular matrix in human SW1353 cells.","date":"2019","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/31678046","citation_count":13,"is_preprint":false},{"pmid":"22192464","id":"PMC_22192464","title":"Administration of antisense DNA for GPR39-1b causes anxiolytic-like responses and appetite loss in rats.","date":"2011","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/22192464","citation_count":13,"is_preprint":false},{"pmid":"26857489","id":"PMC_26857489","title":"Immune malfunction in the GPR39 zinc receptor of knockout mice: Its relationship to depressive disorder.","date":"2015","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/26857489","citation_count":13,"is_preprint":false},{"pmid":"36181628","id":"PMC_36181628","title":"GPR39 Knockout Worsens Microcirculatory Response to Experimental Stroke in a Sex-Dependent Manner.","date":"2022","source":"Translational stroke research","url":"https://pubmed.ncbi.nlm.nih.gov/36181628","citation_count":13,"is_preprint":false},{"pmid":"29079520","id":"PMC_29079520","title":"Zac1/GPR39 phosphorylating CaMK-II contributes to the distinct roles of Pax3 and Pax7 in myogenic progression.","date":"2017","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/29079520","citation_count":12,"is_preprint":false},{"pmid":"39514940","id":"PMC_39514940","title":"ZnR/GPR39 regulates hepatic insulin signaling, tunes liver bioenergetics and ROS production, and mitigates liver fibrosis and injury.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/39514940","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50518,"output_tokens":8887,"usd":0.142429},"stage2":{"model":"claude-opus-4-6","input_tokens":12864,"output_tokens":3591,"usd":0.231143},"total_usd":0.373572,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"GPR39 was cloned as a member of the GHS-R/neurotensin receptor family, sharing structural features including a conserved acidic residue (E124) in TM-3 essential for GHS-R activation; expressed in brain and peripheral tissues.\",\n      \"method\": \"cDNA cloning, genomic hybridization, sequence analysis\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — original cloning paper with structural characterization, single lab\",\n      \"pmids\": [\"9441746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Zn2+ activates GPR39 signaling (inositol phosphate turnover, cAMP production, arrestin mobilization, CRE- and SRE-dependent transcriptional activity) in GPR39-expressing cells; obestatin does not activate GPR39 or bind to it.\",\n      \"method\": \"Cell-based signaling assays (IP turnover, cAMP, arrestin recruitment, reporter gene), radioligand binding, quantitative PCR\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal signaling assays, replicated across labs\",\n      \"pmids\": [\"16959833\", \"17054911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Zn2+ was isolated as an endogenous GPR39 agonist from fetal bovine serum; its calcium-mobilizing activity is abolished by PLC inhibitor U73122 but not pertussis toxin, demonstrating Gαq-PLC coupling; conserved across mouse and rat GPR39.\",\n      \"method\": \"HPLC fractionation of FBS, ICP-MS identification, intracellular calcium mobilization assay, pharmacological inhibitors\",\n      \"journal\": \"Journal of receptor and signal transduction research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical purification of endogenous agonist plus mechanistic pathway dissection\",\n      \"pmids\": [\"17885920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GPR39 exists as a full-length 7TM form (GPR39-1a) with constitutive activity and a truncated 5TM splice variant (GPR39-1b); promoter analysis identified HNF-1α, HNF-4α, and SP1 binding sites controlling GPR39 expression.\",\n      \"method\": \"RT-PCR, quantitative RT-PCR, functional promoter analysis\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — splice variant characterization with functional promoter dissection, single lab\",\n      \"pmids\": [\"17488974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Zn2+ agonism of GPR39 requires His17 and His19 in the N-terminal extracellular segment; Asp313 in ECL3 functions as a tethered inverse agonist, and its substitution eliminates Zn2+-induced activation while greatly increasing constitutive signaling.\",\n      \"method\": \"Alanine-scanning mutagenesis, inositol phosphate production assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic active-site mutagenesis defining agonist binding mechanism\",\n      \"pmids\": [\"18588883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GPR39 contains two disulfide bridges: a conserved bridge (Cys108–Cys210) required for cell surface expression and agonist-induced signaling, and a non-conserved bridge (Cys11–Cys191) that dampens receptor activation; disruption of the second bridge increases Zn2+ potency ~10-fold.\",\n      \"method\": \"Cysteine mutagenesis, TCEP reduction, free sulfhydryl labeling, inositol phosphate assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis plus chemical reduction with complementary readouts\",\n      \"pmids\": [\"18693759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GPR39 constitutive activity signals via Gα13 → RhoA → SRE-mediated transcription, leading to upregulation of PEDF secretion and protection from cell death; RGS16 was identified as a signaling component linking GPR39 to Gα13.\",\n      \"method\": \"Transcriptome array, co-expression with dominant-negative RhoA/SRF, GPR39 overexpression/silencing, PEDF conditioned medium assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple signaling pathway tests, single lab\",\n      \"pmids\": [\"18180304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GPR39 is the molecular identity of the zinc-sensing receptor (ZnR) in keratinocytes; silencing GPR39 abolishes Zn2+-dependent metabotropic Ca2+ responses, downstream MAP kinase activation, NHE1 upregulation, and scratch closure.\",\n      \"method\": \"siRNA silencing of GPR39, fluorometric Ca2+ imaging, MAP kinase assay, scratch wound assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown with multiple orthogonal functional readouts\",\n      \"pmids\": [\"20522546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Synaptic Zn2+ activates GPR39 (mZnR) postsynaptically to upregulate KCC2 surface expression and Cl- transport activity, producing a hyperpolarizing shift in GABAA reversal potential and enhancing inhibitory tone in hippocampal neurons.\",\n      \"method\": \"GPR39 knockout mice, mossy fiber stimulation in hippocampal slices, ZnT3-KO mice, EGABA measurement, KCC2 surface expression assay\",\n      \"journal\": \"Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout, electrophysiology, and biochemistry across multiple mouse models\",\n      \"pmids\": [\"21900570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GPR39 is identified as the molecular moiety of ZnR in colonocytes; GPR39 silencing abolishes Zn2+-dependent Ca2+ release, Na+/H+ exchange upregulation, and butyrate-induced cell death protection; the protection is mediated by GPR39-dependent clusterin upregulation.\",\n      \"method\": \"GPR39 siRNA silencing, Ca2+ imaging, NHE activity assay, GPR39 KO mouse tissue, clusterin knockdown\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA plus KO mouse validation with multiple mechanistic readouts\",\n      \"pmids\": [\"22545109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Extracellular pH regulates ZnR/GPR39 activity through Asp313: substitution of Asp313 to Ala abolishes pH sensitivity, while His17 and His19 replacements do not affect pH dependence, identifying Asp313 as both a Zn2+-binding modulator and pH sensor.\",\n      \"method\": \"Site-directed mutagenesis (Asp313, His17, His19), Ca2+ imaging, ERK1/2 and AKT activation assays, NHE activity assay at varying pH\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure-function mutagenesis with multiple functional readouts\",\n      \"pmids\": [\"22879599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GPR39 activates Gαq/11-RhoA signaling to sustain YAP activity in oral squamous cell carcinoma; inhibition of GPR39 reduces YAP-driven tumor growth.\",\n      \"method\": \"GPR39 overexpression/knockdown, signaling pathway analysis, tumor growth assays\",\n      \"journal\": \"Journal of Dental Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway assignment with functional cancer phenotype, single lab\",\n      \"pmids\": [\"32325008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GPR39 is identified as the receptor mediating Hedgehog pathway inhibition by CMAP compounds downstream of Smoothened; RNA interference knockdown or cDNA overexpression of GPR39 confirmed necessity for compound activity and Gli transcription factor modulation.\",\n      \"method\": \"siRNA knockdown, cDNA overexpression, GPCR mRNA expression correlation, Hh pathway reporter assay, IP turnover assay\",\n      \"journal\": \"Nature Chemical Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain- and loss-of-function with pathway-level mechanistic readout\",\n      \"pmids\": [\"24633354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ZnR/GPR39 interacts with the Ca2+-sensing receptor (CaSR) to synergistically enhance Zn2+-dependent Ca2+ signaling; CaSR silencing or dominant-negative CaSR reduces ZnR/GPR39 activity; co-expression is sufficient to trigger enhanced responses.\",\n      \"method\": \"siRNA silencing of CaSR, dominant-negative CaSR, GPR39 overexpression in HEK293, Ca2+ imaging, MAPK/PI3K assays\",\n      \"journal\": \"Journal of Cellular Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple complementary approaches in single lab\",\n      \"pmids\": [\"24264723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ZnR/GPR39 controls colonocyte proliferation and differentiation via ERK1/2, AKT, and mTOR/p70S6K pathways; silencing ZnR/GPR39 impairs alkaline phosphatase activity (differentiation marker) and reduces tight junction protein (occludin, ZO-1, E-cadherin) expression; GPR39 KO mouse colon shows decreased ZO-1 and occludin.\",\n      \"method\": \"siRNA silencing, Western blot (ERK1/2, AKT, mTOR, caspase-3), alkaline phosphatase assay, TEER measurement, GPR39 KO mice\",\n      \"journal\": \"Cell Death & Disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA plus KO mouse validation with multiple mechanistic readouts\",\n      \"pmids\": [\"24967969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Protein kinase inhibitor β (PKIB) interacts with the C-terminus of GPR39 (identified by Y2H screen); co-expression enhances GPR39 constitutive (Gα13/RhoA/SRE) but not zinc-mediated signaling; zinc causes PKIB dissociation from GPR39, creating a negative-feedback loop on Gs pathway.\",\n      \"method\": \"Yeast-2-hybrid screen, co-expression, SRE reporter assay, cell protection assay, PKIB mutational analysis\",\n      \"journal\": \"Biochemical Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Y2H binding plus functional validation, single lab\",\n      \"pmids\": [\"24869658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GPR39 forms heteroreceptor complexes with 5-HT1A and GalR1; these interactions are modulated by zinc; the 5-HT1A-GPR39 heterocomplex shows additive signaling functionality compared to individual receptors.\",\n      \"method\": \"FRET, co-immunopurification, signaling assays upon receptor activation\",\n      \"journal\": \"Biochimica et Biophysica Acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — FRET and co-IP with functional readout, single lab\",\n      \"pmids\": [\"26365466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"mZnR/GPR39 activation by synaptic Zn2+ release upregulates KCC2 via Gαq/phospholipase C/ERK1/2 signaling cascade; mZnR/GPR39 KO mice have dramatically enhanced seizure susceptibility to kainic acid.\",\n      \"method\": \"GPR39 KO mice, kainic acid seizure model, hippocampal slice electrophysiology, KCC2 surface expression assay, PLC/ERK inhibitors\",\n      \"journal\": \"Neurobiology of Disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with electrophysiology, biochemical pathway dissection\",\n      \"pmids\": [\"25562657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In human myoblasts, obestatin/GPR39 system controls myogenesis: mitogenic ERK1/2/JunD signaling is G protein-dependent, while cell cycle exit and differentiation require β-arrestin 1/2 scaffolding, Src activation, and EGFR transactivation via matrix metalloproteinases.\",\n      \"method\": \"β-arrestin knockdown, EGFR transactivation assays, co-immunoprecipitation, phosphorylation assays, myogenic differentiation markers\",\n      \"journal\": \"Cellular and Molecular Life Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches for pathway dissection, single lab\",\n      \"pmids\": [\"26211463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"mZnR/GPR39 upregulates neuronal Na+/H+ exchanger (NHE) activity via ERK1/2-dependent pathway, enhancing recovery from intracellular acidification; this signaling is abolished at acidic extracellular pH (6.5), providing a homeostatic pH regulation mechanism.\",\n      \"method\": \"GPR39 KO neurons, ERK1/2 phosphorylation assay, NHE activity assay, pH manipulation, hippocampal neurons in vitro\",\n      \"journal\": \"Journal of Neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO neurons plus pharmacological dissection with multiple readouts\",\n      \"pmids\": [\"26375174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Small-molecule GPR39 agonists (LY2784544, GSK2636771) and GPR39-C3 show probe-dependent and pathway-dependent allosteric modulation by physiological zinc concentrations, revealing zinc as an allosteric potentiator of small-molecule GPR39 activation.\",\n      \"method\": \"β-arrestin recruitment assay (PRESTO-Tango), cAMP assay, Gq signaling assay, allosteric modulation experiments\",\n      \"journal\": \"Molecular Pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — unbiased screening plus pharmacological characterization, single lab\",\n      \"pmids\": [\"27754899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GPR39 desensitization occurs via a unique Rho kinase (ROCK)-dependent mechanism: receptor activation induces ROCK-dependent internalization of GPR39; a biased agonist lacking G12/13 activation does not induce desensitization, linking G12/13-ROCK signaling to feedback regulation.\",\n      \"method\": \"ROCK inhibitor (Y-27632), GFP-tagged GPR39 internalization assay, cAMP, IP1, SRF-RE, β-arrestin recruitment assays, biased agonist comparison\",\n      \"journal\": \"Biochemical Pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with receptor localization assay, single lab\",\n      \"pmids\": [\"28619258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ZnR/GPR39 upregulates basolateral KCC1 in colonocytes to enhance Cl- absorption and reduce cholera toxin-induced fluid loss; this effect requires both dietary Zn2+ and ZnR/GPR39, as both are absent in ZnR/GPR39 KO mice.\",\n      \"method\": \"ZnR/GPR39 KO mice, cholera toxin fluid secretion model, KCC activity assay, Caco-2 cells, Ussing chambers\",\n      \"journal\": \"Biochimica et Biophysica Acta - Molecular Basis of Disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse model plus cell-based ion transport assays\",\n      \"pmids\": [\"28093242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Zn2+ acting via ZnR/GPR39 activates Gαq-PLC signaling in endothelial cells, promoting cell survival/growth through cAMP and AKT, VEGF-A and PDGF-αR upregulation, and cytoskeletal reorganization; siRNA knockdown of GPR39 abolishes these effects.\",\n      \"method\": \"GPR39 siRNA, Ca2+ imaging, Gαq-PLC pathway analysis, GPR39 KO endothelial cells, tube formation assay\",\n      \"journal\": \"American Journal of Physiology - Cell Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA and KO cells with multiple functional readouts, single lab\",\n      \"pmids\": [\"29351417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Zn2+ signals via ZnR/GPR39 to induce IL-6 production from skin fibroblasts through GPR39-mediated pathways; ZnT2 transporter is required for Zn2+ release from mast cell granules; wound healing is impaired in GPR39 KO and IL-6 KO mice.\",\n      \"method\": \"GPR39 KO mice, IL-6 KO mice, ZnT2 KO mice, wound healing model, cytokine measurement\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple KO models with clear phenotypic readout, single lab\",\n      \"pmids\": [\"31346193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Zinc supplementation via GPR39 upregulates PKCζ, which enhances ZO-1 expression and epithelial integrity in Salmonella-infected Caco-2 cells; siRNA silencing of GPR39 reduces zinc-activated PKCζ and blocks zinc's protective effect on barrier integrity.\",\n      \"method\": \"siRNA silencing of GPR39 and PKCζ, TEER measurement, Western blot, tight junction protein analysis\",\n      \"journal\": \"Journal of Nutrition\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal siRNA knockdowns with pathway validation, single lab\",\n      \"pmids\": [\"28515165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ZnR/GPR39 activates tight junction assembly in intestinal epithelial cells via a PLC-CaMKKβ-AMPK signaling cascade; PLC and CaMKKβ inhibitors abolish GPR39 agonist-induced AMPK activation and tight junction assembly.\",\n      \"method\": \"GPR39 agonist TC-G 1008, pharmacological inhibitors (PLC, CaMKKβ, AMPK), TEER, Western blot for AMPK phosphorylation, ZO-1 immunofluorescence\",\n      \"journal\": \"European Journal of Pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with multiple inhibitors and functional readouts\",\n      \"pmids\": [\"30459126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ZnR/GPR39 upregulates KCC3 (not KCC4) activity in tamoxifen-resistant breast cancer cells, promoting cell migration and proliferation; KCC3 silencing or ZnR/GPR39 silencing abolishes Zn2+-dependent K+/Cl- co-transport and scratch closure.\",\n      \"method\": \"siRNA silencing of ZnR/GPR39 and KCC isoforms, NH4+ transport assay (pH surrogate for K+/Cl- transport), scratch closure assay, KCC inhibitor DIOA\",\n      \"journal\": \"Cell Calcium\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — isoform-selective siRNA with transport and migration assays, single lab\",\n      \"pmids\": [\"31146164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Amyloid-β attenuates mZnR/GPR39-dependent Ca2+ responses, ERK1/2 phosphorylation, and clusterin upregulation in neurons by binding Zn2+ and preventing receptor activation; AKT phosphorylation is not mZnR/GPR39-dependent and is unaffected by Aβ.\",\n      \"method\": \"GPR39 KO mouse cortical neurons, SHSY-5Y cells, Ca2+ imaging, ERK1/2/AKT phosphorylation, Aβ treatment, mZnR/GPR39 siRNA silencing\",\n      \"journal\": \"Journal of Neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO neurons plus siRNA with multiple pathway-specific readouts\",\n      \"pmids\": [\"27501363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GPR39 KO osteoblasts have disorganized matrix deposition with abnormally low collagen and high mineral contents; Gpr39-/- mice show reduced Zip13 expression and downregulation of zinc-dependent ADAMTS metalloprotease family members involved in collagen processing.\",\n      \"method\": \"GPR39 KO mice and primary osteoblast cultures, FTIR spectroscopy, histology, Western blot, Zn transporter expression analysis\",\n      \"journal\": \"FASEB Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse and cell-autonomous phenotype with mechanistic gene expression analysis\",\n      \"pmids\": [\"29295862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GPR39 agonism promotes osteoblast differentiation via AMPK-mediated Runx-2 induction; AMPK inhibition by Compound C abolishes TC-G 1008-mediated ALP, osteocalcin, and collagen induction.\",\n      \"method\": \"GPR39 agonist TC-G 1008, AMPK inhibitor Compound C, ALP activity assay, calcium deposition, Western blot for Runx-2 and AMPK\",\n      \"journal\": \"Artificial Cells, Nanomedicine, and Biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — agonist plus inhibitor with differentiation markers, single lab\",\n      \"pmids\": [\"31448639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GPR39 agonism protects against neuroinflammation post-hypoxic-ischemia via SIRT1/PGC-1α/Nrf2 pathway; GPR39 CRISPR, PGC-1α CRISPR, and SIRT1 inhibitor EX527 abolish TC-G 1008 neuroprotection.\",\n      \"method\": \"CRISPR knockout of GPR39 and PGC-1α, SIRT1 inhibitor, neonatal rat HIE model, Western blot, immunofluorescence\",\n      \"journal\": \"Journal of Neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological pathway dissection in vivo, single lab\",\n      \"pmids\": [\"34645465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GPR39-mediated pericyte contraction during reduced coronary perfusion pressure causes capillary constriction leading to 'no reflow' after myocardial infarction; GPR39 KO and GPR39 inhibitor (VC43) treatment reduce no-reflow zones and infarct size.\",\n      \"method\": \"GPR39 KO mice, coronary occlusion/reperfusion model, GPR39 inhibitor VC43, immunohistochemistry for capillary density and diameter\",\n      \"journal\": \"American Journal of Physiology - Heart and Circulatory Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO plus pharmacological inhibition with anatomical and functional readouts, single lab\",\n      \"pmids\": [\"34623177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Oral GPR39 agonist (Cpd1324) increases GLP-1 secretion via Gαq and Gαi/o (but not Gαs) signaling in intestinal L cells; this is GPR39-dependent as GPR39 KO organoids do not respond; acute food intake is decreased and GLP-1 levels are elevated in HFD-fed mice.\",\n      \"method\": \"Bioluminescence resonance energy transfer (BRET) biosensors for G protein activation, mouse/human intestinal organoids, GPR39 KO organoids, plasma hormone measurement\",\n      \"journal\": \"Molecular Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — BRET assay for G protein coupling specificity plus KO organoid validation\",\n      \"pmids\": [\"33711555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Extracellular Zn2+ released from thymocytes after HCT conditioning activates GPR39 on endothelial cells to stimulate BMP4 production, promoting thymic regeneration and T-cell reconstitution; GPR39 agonist enhances thymic function without requiring prior Zn2+ accumulation.\",\n      \"method\": \"GPR39 KO mice, bone-marrow transplantation model, lineage tracing, small-molecule GPR39 agonist, measurement of BMP4 and recent thymic emigrants\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse plus agonist pharmacology with defined cellular mechanism, single lab\",\n      \"pmids\": [\"35357432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GPR39 directly binds SUFU (suppressor of fused), an endogenous inhibitor of the Sonic Hedgehog pathway; overexpression or activation of GPR39 suppresses basal and ligand-dependent GLI1 activation and EC migration; GPR39 KO enhances revascularization in diabetic hindlimb ischemia.\",\n      \"method\": \"Co-immunoprecipitation of GPR39 and SUFU, adenoviral GPR39 overexpression, siRNA knockdown, SUFU overexpression rescue, GPR39 KO mouse ischemia model\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding (Co-IP) plus epistasis (SUFU rescue) plus KO in vivo, single lab\",\n      \"pmids\": [\"36574661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GPR39 is an evolutionarily conserved receptor for bile acids, particularly 3-O-sulfated lithocholic acids; GPR39 is sufficient for bile acid-induced Ca2+ elevation in cultured cells and mediates Ca2+ elevation and necrosis in pancreatic acinar cells; GPR39 KO mice show significantly reduced bile acid-induced acute pancreatitis.\",\n      \"method\": \"Cell-line Ca2+ assay with GPR39 expression, pancreatic acinar cell Ca2+ and necrosis assays, GPR39 KO mice in bile acid-induced pancreatitis model\",\n      \"journal\": \"Science Advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — receptor sufficiency assay plus genetic KO in vivo disease model\",\n      \"pmids\": [\"38306436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Bone-marrow macrophage-derived GPNMB binds directly to GPR39 as a ligand; GPR39 mediates GPNMB's beneficial effects on post-MI cardiac repair; GPR39 KO abrogates the protective effects of GPNMB on myocyte contraction and fibroblast activation.\",\n      \"method\": \"Lineage tracing, bone-marrow transplantation, genetic loss-of-function (GPNMB KO, GPR39 KO), viral GPNMB delivery, single-cell transcriptomics, receptor binding identification\",\n      \"journal\": \"Nature Cardiovascular Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — identification of GPNMB as GPR39 ligand with genetic epistasis (GPR39 KO abrogates GPNMB effects), multiple complementary methods\",\n      \"pmids\": [\"39455836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ZnR/GPR39 modulates hepatic insulin receptor signaling: KO mice show elevated insulin receptor expression and AKT activation, higher fasting glucose, hepatic lipid accumulation, increased OCR and ROS, and marked liver fibrosis with elevated collagen; ZnR/GPR39 also regulates ERK1/2 phosphorylation in liver.\",\n      \"method\": \"GPR39 KO mice, Western blot (insulin receptor, AKT, ERK1/2), hepatic OCR/ROS measurement, LPS-induced ALI model, serum cytokines, collagen staining\",\n      \"journal\": \"Redox Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with multiple metabolic and signaling readouts, single lab\",\n      \"pmids\": [\"39514940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GPR39 promotes cardiac hypertrophy by inhibiting AMPK, leading to mTOR and S6K1 activation and increased de novo protein synthesis; adeno-associated virus GPR39 knockdown suppresses TAC-induced hypertrophy, and rapamycin blocks GPR39 overexpression-induced protein synthesis.\",\n      \"method\": \"AAV9-mediated GPR39 knockdown, adenovirus GPR39 overexpression, TAC mouse model, mTOR inhibitor rapamycin, Western blot for AMPK/mTOR/S6K1, cardiomyocyte size measurement\",\n      \"journal\": \"Cell Biology International\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gene manipulation plus pharmacological mTOR inhibition, single lab\",\n      \"pmids\": [\"33554444\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GPR39 is a constitutively active, Zn2+-sensing class A GPCR that couples to Gαq (triggering PLC-IP3-Ca2+ and downstream ERK1/2, AKT, mTOR signaling), Gαs (cAMP), and Gα12/13 (RhoA-SRE transcription); Zn2+ binds through His17/His19 in the N-terminal domain, with Asp313 in ECL3 functioning as both a tethered inverse agonist and pH sensor, and a non-conserved disulfide bridge (Cys11–Cys191) dampening receptor activation; downstream, GPR39 regulates KCC2 and KCC1/3 ion cotransporter activity in neurons and epithelia, controls colonocyte proliferation/differentiation and tight junction integrity, promotes thymic regeneration via BMP4, participates in the Hedgehog pathway by binding SUFU, can be activated by bile acids (particularly 3-O-sulfated lithocholic acids) and by macrophage-derived GPNMB, and undergoes Rho kinase (ROCK)-dependent desensitization and internalization.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GPR39 is a constitutively active class A GPCR that functions as a zinc-sensing receptor (ZnR) and integrates extracellular Zn²⁺, bile acid, and GPNMB signals into diverse intracellular cascades across epithelial, neuronal, endothelial, and immune cell types. Zn²⁺ binds via His17/His19 in the N-terminal domain while Asp313 in ECL3 serves as both a tethered inverse agonist and pH sensor; the receptor couples to Gαq (PLC–IP3–Ca²⁺–ERK1/2), Gαs (cAMP), and Gα12/13 (RhoA–SRE transcription), with desensitization proceeding through a ROCK-dependent internalization pathway [PMID:16959833, PMID:18588883, PMID:22879599, PMID:28619258]. In neurons, synaptically released Zn²⁺ activates GPR39 to upregulate KCC2 surface expression via Gαq/PLC/ERK1/2, shifting GABA_A reversal potential and enhancing inhibitory tone, while in colonocytes and other epithelia GPR39 drives tight junction assembly, ion cotransporter (KCC1/3, NHE) regulation, and proliferation/differentiation through ERK1/2–AKT–mTOR signaling [PMID:21900570, PMID:24967969, PMID:28093242]. GPR39 also serves as a receptor for 3-O-sulfated lithocholic acids mediating bile acid–induced Ca²⁺ signaling and pancreatic acinar cell injury, and for macrophage-derived GPNMB promoting post-myocardial infarction cardiac repair [PMID:38306436, PMID:39455836].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Cloning of GPR39 established it as a novel orphan GPCR within the GHS-R/neurotensin receptor family, setting the stage for ligand identification and functional characterization.\",\n      \"evidence\": \"cDNA cloning, genomic hybridization, and sequence analysis in human tissues\",\n      \"pmids\": [\"9441746\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No ligand or signaling pathway identified\", \"Functional role entirely unknown\", \"Expression pattern only broadly characterized\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identification of Zn²⁺ as the endogenous GPR39 agonist resolved the orphan receptor problem and revealed multi-pathway G protein coupling (Gαq–PLC, Gαs–cAMP, Gα13–RhoA–SRE), while definitively excluding obestatin as a ligand.\",\n      \"evidence\": \"HPLC fractionation of fetal bovine serum with ICP-MS identification, cell-based IP turnover, cAMP, β-arrestin, and reporter assays; pharmacological pathway dissection with PLC inhibitor and pertussis toxin\",\n      \"pmids\": [\"16959833\", \"17054911\", \"17885920\", \"18180304\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Zn²⁺ binding site on receptor not yet mapped\", \"Physiological contexts of each G protein pathway unclear\", \"In vivo relevance of zinc sensing not demonstrated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Systematic mutagenesis defined the structural determinants of GPR39 activation: His17/His19 as the Zn²⁺ coordination site, Asp313 as a tethered inverse agonist, and a non-conserved disulfide (Cys11–Cys191) as a negative modulator of receptor sensitivity.\",\n      \"evidence\": \"Alanine-scanning and cysteine mutagenesis with inositol phosphate assays, TCEP reduction, and free sulfhydryl labeling\",\n      \"pmids\": [\"18588883\", \"18693759\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure available\", \"Contribution of each residue to G protein selectivity unknown\", \"Mechanism by which Asp313 enforces inverse agonism at the structural level unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing GPR39 as the molecular identity of the zinc-sensing receptor (ZnR) in keratinocytes and colonocytes linked it to physiological processes including wound healing and epithelial cytoprotection.\",\n      \"evidence\": \"siRNA silencing of GPR39 abolishes Zn²⁺-dependent Ca²⁺ responses, MAP kinase activation, and scratch wound closure in keratinocytes; GPR39 KO mouse colon validates colonocyte signaling\",\n      \"pmids\": [\"20522546\", \"22545109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo wound healing phenotype in GPR39 KO mice not yet tested at this stage\", \"Relative contribution of GPR39 vs. other zinc importers to zinc sensing unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovery that synaptically released Zn²⁺ activates postsynaptic GPR39 to upregulate KCC2 and shift GABAergic inhibition established GPR39 as a neuronal zinc sensor regulating excitation-inhibition balance.\",\n      \"evidence\": \"GPR39 KO and ZnT3 KO mice, hippocampal slice electrophysiology, KCC2 surface expression assay, EGABA measurement\",\n      \"pmids\": [\"21900570\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GPR39 loss contributes to neuropsychiatric disease in humans unknown\", \"Role in other brain regions beyond hippocampal mossy fibers not explored\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of Asp313 as a pH sensor (distinct from the Zn²⁺-binding His17/His19) revealed that GPR39 integrates two extracellular signals—zinc concentration and pH—to modulate downstream ERK1/2 and AKT activation.\",\n      \"evidence\": \"Site-directed mutagenesis of Asp313, His17, His19 with Ca²⁺ imaging and ERK/AKT/NHE activity at varying pH\",\n      \"pmids\": [\"22879599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether pH and Zn²⁺ bind the same or distinct receptor conformations is unresolved\", \"In vivo relevance of pH sensing (e.g., in ischemic tissue) not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Multiple studies converged to show GPR39 governs colonocyte proliferation, differentiation, and tight junction integrity via ERK1/2–AKT–mTOR, and participates in Hedgehog pathway regulation by modulating Gli transcription factor activity.\",\n      \"evidence\": \"siRNA/KO in colonocytes measuring differentiation markers, TEER, and tight junction proteins; reciprocal gain/loss-of-function in Hh reporter assays\",\n      \"pmids\": [\"24967969\", \"24633354\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct GPR39–SUFU interaction not yet demonstrated at this stage\", \"Relationship between Zn²⁺ and Hedgehog modulation not clarified\", \"Whether epithelial barrier effects are cell-autonomous in vivo unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"GPR39 KO mice showed dramatically enhanced seizure susceptibility, establishing the Gαq/PLC/ERK–KCC2 axis as physiologically critical for neuronal inhibitory tone and revealing GPR39 as a seizure susceptibility modifier.\",\n      \"evidence\": \"GPR39 KO mice subjected to kainic acid, hippocampal electrophysiology, KCC2 surface expression, PLC/ERK inhibitors\",\n      \"pmids\": [\"25562657\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Human genetic association with epilepsy not demonstrated\", \"Therapeutic potential of GPR39 agonists in seizure models not tested at this point\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"GPR39 desensitization was shown to proceed through a unique ROCK-dependent internalization mechanism downstream of Gα12/13, distinguishing it from canonical GRK/β-arrestin–mediated GPCR desensitization, and colonic KCC1 regulation linked GPR39 to chloride absorption and diarrheal disease protection.\",\n      \"evidence\": \"ROCK inhibitor Y-27632 and biased agonist experiments for desensitization; GPR39 KO mice in cholera toxin fluid secretion model with Ussing chamber ion transport\",\n      \"pmids\": [\"28619258\", \"28093242\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ROCK-dependent desensitization occurs for all GPR39-expressing cell types unknown\", \"Structural basis for biased agonism at GPR39 not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"GPR39 was linked to cardiac hypertrophy (via AMPK inhibition–mTOR activation), neuroprotection (via SIRT1/PGC-1α/Nrf2), GLP-1 secretion from intestinal L cells (via Gαq/Gαi/o), and thymic regeneration (via BMP4), greatly expanding its physiological scope beyond zinc sensing.\",\n      \"evidence\": \"AAV9-mediated knockdown in TAC model; CRISPR KO in neonatal HIE model; BRET G protein biosensors and GPR39 KO organoids; GPR39 KO mice in bone marrow transplant model\",\n      \"pmids\": [\"33554444\", \"34645465\", \"33711555\", \"35357432\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ligand identity driving GPR39 in cardiac hypertrophy unclear (Zn²⁺ vs. other)\", \"Whether GPR39 agonists are therapeutically viable in these contexts untested in humans\", \"Relative contribution of Gαq vs. Gαi/o to GLP-1 secretion not fully dissected\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Direct physical interaction between GPR39 and SUFU provided a mechanistic basis for GPR39's suppression of Hedgehog/GLI1 signaling, and GPR39 KO enhanced revascularization, placing GPR39 at the intersection of GPCR and Hedgehog pathways.\",\n      \"evidence\": \"Co-immunoprecipitation of GPR39 and SUFU, SUFU overexpression rescue, GPR39 KO in diabetic hindlimb ischemia model\",\n      \"pmids\": [\"36574661\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the GPR39–SUFU interaction is zinc-dependent unknown\", \"Structural basis of GPR39–SUFU binding uncharacterized\", \"Relevance to developmental Hedgehog signaling not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"GPR39 was deorphanized further as a receptor for 3-O-sulfated bile acids (mediating pancreatitis) and for macrophage-derived GPNMB (mediating post-MI cardiac repair), establishing GPR39 as a multi-ligand receptor with tissue-specific disease roles.\",\n      \"evidence\": \"GPR39-expressing cell Ca²⁺ sufficiency assays, GPR39 KO mice in bile acid–induced pancreatitis and post-MI models, genetic epistasis with GPNMB KO\",\n      \"pmids\": [\"38306436\", \"39455836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Zn²⁺, bile acids, and GPNMB compete or cooperate at the receptor binding site is unknown\", \"Structural basis for multi-ligand recognition not resolved\", \"Whether bile acid and GPNMB signals use the same or distinct G protein pathways through GPR39 is undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"No high-resolution structure of GPR39 exists, and the mechanisms by which three chemically distinct ligands (Zn²⁺, sulfated bile acids, GPNMB) activate the same receptor—potentially through distinct binding sites and biased signaling—remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No cryo-EM or crystal structure\", \"Allosteric vs. orthosteric binding of each ligand class not mapped\", \"In vivo hierarchy of ligands in different tissues unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 2, 4, 36, 37]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 5, 7, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2, 6, 11, 17, 33, 36, 37]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [12, 35]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [34]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [8, 17, 22, 27]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [36, 37, 39]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SUFU\",\n      \"GPNMB\",\n      \"CASR\",\n      \"PKIB\",\n      \"HTR1A\",\n      \"GALR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}